COVID Research at ANSTO

COVID Research Support

Australia’s nuclear science capabilities at ANSTO, which represent a significant national asset, have been central to the fight against COVID.

Our team of scientists are fast-tracking support for researchers from around the globe, who are busy working on treatments and new vaccines for COVID.

20th July 2023

Synchrotron light illuminates key structures in study on genetic basis for COVID-19 immunity

Today an international team has provided a molecular basis for strong immunity against COVID-19.

News

Innovation

30th June 2023

Deuteration continues to be an important characterisation tool in understanding COVID infectivity and severity

A large collaboration of European investigators gained insights into how the SARS-CoV-2 spike protein (S protein) impacts with lipid metabolism in the body with implications for COVID-19 infection and mRNA vaccination.

News

Innovation

17th March 2022

ANSTO contributes to new understanding of how COVID infects humans

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

News

17th September 2021

Understanding how adaptive immune cells recognise and interact with the SARS CoV-2 virus

A team of scientists led by Monash University and the University of Melbourne in association with the Peter Doherty Institute for Infection and Immunity have made progress in clarifying the molecular interactions that underpin how our adaptive immune cells recognise SARS CoV-2, which causes COVID-19.

News

28th July 2021

Research supports potential local supply chain for component in COVID PCR test

University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.

News

17th June 2021

Research finds possible key to long term COVID-19 symptoms

Researchers from La Trobe University have used the Australian Synchrotron to help identify a key mechanism in how SARS-CoV-2 damages lung tissue.

News

7th June 2021

The power of deuteration brings insight for mRNA-based drug delivery and vaccines

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

Innovation

National Deuteration Facility

27th May 2021

ANSTO contributes to new research could pave the way for safer and more efficient COVID-19 testing

International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

News

Innovation

23rd February 2021

Progress on understanding what makes COVID-19 more infectious than SARS

Researchers led by the University of Bristol (UK) have identified a possible cause of SARS-CoV-2’s increased infectivity compared to SARS-CoV

News

25th August 2020

More progress on understanding COVID-19

Understanding how COVID supresses the immune system may lead to antiviral strategies

Australian Synchrotron

11th August 2020

Unique immune system of the alpaca being used in COVID-19 research

Scientists from the Walter and Eliza Hall Institute (WEHI) are using the unique immune system of the alpaca and techniques at the Australian Synchrotron as part of research using antibodies to disrupt COVID-19 viral entry into cells.

News